Beyond the simple long term business thesis there is the current valuation on $MRVI
TLDR: MRVI is a no brainer

- MC = $800M
- EV = $1.1B
- 2 divisions = 1) NAP  2) BST
- Both have unique and essential products
- NAP is best in class
- BST is involved in 100% of FDA CGT products.